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OBJECTIVES The aim of this study was to clarify the clinical significance and the determinant of
microvolt-level T-wave alternans (TWA) in patients with dilated cardiomyopathy (DCM).
BACKGROUND The prevention of sudden death in patients with DCM remains the therapeutic target.
T-wave alternans has been proposed as a powerful tool for identification of patients at high
risk for ventricular arrhythmias and sudden death in coronary artery disease.
METHODS In 58 DCM patients, TWA was measured during bicycle exercise testing using a CH 2000
system (Cambridge Heart, Bedford, Massachusetts). The New York Heart Association class,
signal-averaged electrocardiogram, QT dispersion, left ventricular end-diastolic diameter
(LVDd) and percent fractional shortening detected by echocardiogram and the grade of the
ventricular arrhythmia were obtained in all patients.
RESULTS T-wave alternans was positive in 23 patients (TWA1 group), negative in 25 (TWA2 group)
and indeterminate in 10. Univariate analysis showed that the percentage of patients with
ventricular tachycardia (VT) and the LVDd in the TWA1 group was significantly higher
than those in the TWA2 group (61% vs. 8%, p , 0.001 and 65 6 11 mm vs. 58 6 8 mm,
p , 0.05, respectively). The sensitivity, specificity and predictive accuracy of TWA for VT
were 88%, 72% and 77%, respectively. Multivariate analysis showed that the presence of VT
was a major independent determinant of TWA in patients with DCM (p 5 0.003).
CONCLUSIONS T-wave alternans was closely related to VT in patients with DCM. T-wave alternans is a
useful noninvasive test for identifying high risk patients with DCM who have VT. (J Am
Coll Cardiol 1999;34:374–80) © 1999 by the American College of Cardiology
Dilated cardiomyopathy (DCM) has traditionally been
considered to be a disease with a severe prognosis often
leading to sudden death or death from deteriorating con-
gestive heart failure. The addition of angiotensin-converting
enzyme inhibitor to the conventional therapy significantly
reduced the mortality and hospitalization in patients with
congestive heart failure (1). However, the prevention of
sudden death in patients with DCM remains the therapeu-
tic target. To identify patients at high risk for sudden death
with noninvasive testing, signal-averaged electrocardiogram
(SAECG), QT dispersion (QTd), exercise testing, heart
rate variability and echocardiography have been used. How-
ever, there has been no powerful noninvasive test for
identifying patients at high risk for sudden death in patients
with DCM (2–9). In recent years, microvolt-level T-wave
alternans (TWA) has been proposed as a powerful exami-
nation tool for the identification of patients at high risk for
ventricular arrhythmias and sudden death in coronary artery
disease. However, the clinical significance of TWA in
patients with DCM has been unknown. The aim of this
study was to clarify the clinical significance and the deter-
minant of TWA in patients with DCM.
METHODS
Patients. The study population consisted of 58 consecutive
patients with DCM who were referred to the Kobe Uni-
versity School of Medicine Hospital. The clinical diagnosis
of nonischemic dilated cardiomyopathy was made according
to the criteria recommended by the World Health Organi-
zation and the National Heart, Lung and Blood Institute
(10,11). The clinical characteristics of the 58 study patients
with DCM are summarized in Table 1. All patients un-
derwent noninvasive and invasive evaluation including a
physical examination, 12-lead electrocardiogram, chest ra-
diography, M-mode and two-dimensional Doppler echo-
cardiography, 24-h Holter monitoring, exercise stress test-
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ing, diagnostic right and left cardiac catheterization with
coronary angiography and left ventriculography. All clinical
testing was performed within three weeks except for coro-
nary angiography and left ventriculography. Ventricular
tachycardia (VT) was defined as $3 consecutive ventricular
ectopic beats. If VT lasted for $30 s, it was defined as
sustained VT. Patients were excluded if exercise was not
possible (for example, because of joint pain), if atrial
fibrillation was present or if a permanent pacemaker had
previously been implanted. Ten patients with indeterminate
TWA were excluded from the comparison of clinical
parameters in this study, and a total of 48 patients with
DCM was studied.
Measurements of TWA. The purpose of the study was
explained to all participants, who gave their consent.
T-wave alternans was measured at rest and during con-
trolled bicycle exercise testing using a CH 2000 system
(Cambridge Heart, Bedford, Massachusetts). This system
used the spectral method described by Smith et al. (12). We
performed TWA testing as described by Rosenbaum et al.
(13,14). The alternans analysis was performed blind to all
clinical data. The following were the positivity and negativ-
ity criteria for an alternans test. If there was a sustained
alternans voltage $1.9 mV and alternans ratio $3 with an
onset heart rate #110 beats/min during exercise, the test
was positive. If alternans was not present during a sustained
interval of exercise without artifact at a heart rate $105
beats/min the test was negative. If a record did not meet the
positivity or negativity criteria, the record was considered
indeterminate (12–16).
Measurements of SAECG. Orthogonal bipolar X, Y and
Z leads were recorded until a noise level of 0.4 mV was reached
using standard techniques (Fukuda Denshi FDX-6521, To-
kyo, Japan). The recorded signal was digitized, and the
resultant data underwent signal averaging and filtering using a
bandpass filter with a range of 40 to 250 Hz. The QRS
duration, root mean square voltage of the terminal 40 ms of the
filtered QRS complex (RMS 40) and the duration of the low
amplitude (,40 Hz) signals of the terminal filtered QRS
complex (LAS 40) were calculated by an automated algorithm.
In patients with a normal QRS complex (QRS #110 ms), the
SAECG by time-domain analysis was considered to be posi-
tive if: 1) filtered QRS duration was .114 ms and 2) RMS 40
was ,20 mV or LAS 40 was .38 ms at 40-Hz filtering. In
patients with a wide QRS complex (QRS .110 ms), the
SAECG was considered to be positive if two or three of the
following criteria were positive: 1) filtered QRS duration was
.145 ms; 2) RMS 40 was ,17 mV; and 3) LAS 40 was
.45 ms at 40-Hz filtering (6,17,18).
Measurements of QT dispersion. Standard electrocardio-
grams with simultaneous 12-lead acquisition were recorded
at a paper speed of 25 mm/s. The investigator was blinded
with respect to the patient profile. Patients with a wide QRS
complex (QRS .110 ms, i.e., bundle branch block) were
excluded from the assessment of ventricular repolarization
using the QT interval. QT intervals were measured manu-
ally with calipers in a blinded fashion from the onset of the
QRS complex to the end of the T wave, defined as the
return to the TP baseline. When U waves were present, the
QT interval was measured to the nadir of the curve between
the T and U waves. If the end of the T wave could not be
identified, the lead was not included. A minimum of eight
leads in which the QT interval could be measured was
required for the QTd to be determined. The QTd was
defined as the difference between the longest and shortest
QT intervals.
Statistical analysis. Data were expressed as mean 6 1 SD.
Univariate analysis was performed by unpaired t tests and
chi-square tests between patients in the TWA-positive
group and those in the TWA-negative group. A p value
,0.05 was considered significant. Logistic regression anal-
ysis was performed using TWA as a response variable and
six variables (New York Heart Association [NYHA] class,
left ventricular end-diastolic diameter [LVDd], percent
fractional shortening [%FS], QTd, SAECG and VT) as
explanatory variables. Furthermore, a variable selection was
performed using a forward stepwise method. We used six
explanatory variables as candidate variables. Significant
Table 1. Clinical Characteristics
n 58
Age (yr) 52 6 14
Gender (n)
Male 49
Female 9
NYHA 1.6 6 0.8
BP (mm Hg)
Systole 123 6 19
Diastole 75 6 11
CTR (%) 52 6 7
Data presented are mean value 6 SD or the number of subjects. BP 5 blood pressure;
CTR 5 cardiothoracic ratio; NYHA 5 New York Heart Association class.
Abbreviations and Acronyms
DCM 5 dilated cardiomyopathy
%FS 5 percent fractional shortening
HCM 5 hypertrophic cardiomyopathy
LAS 40 5 duration of the low amplitude (,40 Hz)
signals of the terminal filtered QRS complex
LVDd 5 left ventricular end-diastolic diameter
NYHA 5 New York Heart Association
QTd 5 QT dispersion
RMS 40 5 root mean square voltage of the terminal
40 ms of the filtered QRS complex
SAECG 5 signal-averaged electrocardiogram
TWA 5 T-wave alternans
VF 5 ventricular fibrillation
VT 5 ventricular tachycardia
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factors detected by univariate analysis were reassessed by a
forward stepwise logistic regression analysis with values for
inclusion and elimination set at p 5 0.05 and p 5 0.10,
respectively. The results of the logistic regression analysis
were presented as estimated odds ratios. A value of p , 0.05
was considered to be statistically significant. Data process-
ing and analysis were performed with the Statistical Package
for the Social Science Program (SPSS, Chicago, Illinois).
RESULTS
T-wave alternans. Fifty-eight patients with DCM were
enrolled into the study. T-wave alternans was positive in 23
patients (40%), negative in 25 (43%) and indeterminate in
10 (17%). A representative example of a positive TWA is
shown in Figure 1. Ten patients with indeterminate TWA
were excluded from further evaluation. There were 39 men
(81%) and 9 women (19%) (mean age 49 6 13 years, range
25 to 69) in the study. There was no significant difference
between patients with and without TWA in age, gender,
NYHA classification, %FS, QTd or SAECG (Table 2, Fig.
2). The patient-specific heart rate threshold for the detec-
tion of TWA was 97 6 11 beats/min in patients with
TWA.
New York Heart Association classification. The NYHA
classification was 1.7 6 1.0 in patients with TWA and 1.4 6
0.7 in patients without TWA (p 5 NS) (Table 2).
Figure 1. A representative case of a trend graph of alternans (left side) and the T-wave spectrum (right side) during exercise testing.
An alternans voltage $1.9 mV with an alternans ratio $3 is found at a 0.5-cycle/beat frequency with a heart rate (HR) of .105
beats/min. VT 5 ventricular tachycardia; y.o. 5 year old.
376 Adachi et al. JACC Vol. 34, No. 2, 1999
TWA in Patients With DCM August 1999:374–80
Echocardiography. The LVDd was 65 6 11 ms in pa-
tients with TWA and 58 6 8 ms in patients without TWA.
This difference reached statistical significance (p , 0.05).
The %FS was 18 6 7% in patients with TWA and 21 6 6%
in patients without TWA (p 5 NS) (Fig. 2).
QT dispersion. There were 15 patients with TWA with a
normal QRS complex, and 22 patients without TWA with
a normal QRS complex. In patients with TWA with a
normal QRS complex, QTd was 74 6 25 ms, and in
patients without TWA with a normal QRS complex, QTd
was 64 6 16 ms (p 5 NS) (Fig. 2). The sensitivity,
specificity and predictive accuracy of an increased QTd
(QTd .100 ms) for VT were 30%, 100% and 80%,
respectively.
Signal-averaged electrocardiogram. The SAECG was
positive in 12 patients. The SAECG was positive in eight
patients with TWA (35%), compared with only four pa-
tients without TWA (16%) (p 5 NS) (Fig. 3). The filtered
QRS was 137 6 31 ms in patients with TWA and 118 6
20 ms in patients without TWA (p 5 NS). The RMS 40
was 43 6 39 mV in patients with TWA and 30 6 19 mV in
patients without TWA (p 5 NS). The LAS 40 was 30 6
10 ms in patients with TWA and 33 6 7 mV in patients
without TWA (p 5 NS). All patients with DCM had an
abnormal filtered QRS. Of 16 patients with VT, the
SAECG was positive in 5 patients (31%) and of 32 patients
without VT, it was positive in 7 patients (22%) (p 5 NS).
The sensitivity, specificity and predictive accuracy of the
SAECG for VT were 31%, 78% and 63%, respectively.
Holter monitoring. Ventricular tachycardia was present in
16 out of 48 patients with DCM by 24-h Holter monitor-
ing. Two patients had sustained VT and one patient had
ventricular fibrillation (VF). Ventricular tachycardia was
present in 14 patients with TWA (61%) and 2 patients
without TWA (8%) (p , 0.001) (Fig. 3). Three patients
with sustained VT/VF were all TWA positive. The sensi-
tivity, specificity and predictive accuracy of TWA for VT
were 88%, 72% and 77%, respectively. The specificity of
TWA for VT was inferior to that of the QTd and SAECG,
but the sensitivity of TWA for VT was superior to that of
the QTd and SAECG. Univariate analysis showed that
LVDd and VT were significantly related to TWA in
patients with DCM. Multiple logistic regression analysis
using a forward stepwise method showed that VT was a
major independent determinant of TWA (odds ratio 5
4.00; p 5 0.003) in patients with DCM (Table 3).
DISCUSSION
The problem of sudden cardiac death in patients with
DCM. Dilated cardiomyopathy is a primary disease of the
heart muscle usually involving the dilation of all four
chambers but principally the left ventricle. The prognosis
for patients afflicted with DCM has been poor, with a high
mortality rate of 25% to 50% in the first two years after
diagnosis (3,4,19). Furthermore, approximately half of these
deaths occur suddenly and unexpectedly (3,20). Therefore,
from a public health viewpoint, identification and treatment
of high risk patients before they experience a major arrhyth-
mic event is expected to have the greatest effect on the
problem of sudden cardiac death. Unfortunately, current
attempts to risk-stratify patients further with noninvasive
testing such as echocardiography, SAECG, heart rate vari-
ability and QTd have had limited success (2–9,21). The
present study showed that neither the SAECG nor QTd
Table 2. Clinical Characteristics in Patients With or
Without TWA
n
Age
(yr)
Gender
(M/F) NYHA
TWA1 23 50 6 13 20/3 1.7 6 1.0
TWA2 25 49 6 15 19/6 1.4 6 0.7
p value NS NS NS
Data presented are mean value 6 SD. NYHA 5 New York Heart Association class;
TWA 5 T-wave alternans.
Figure 2. The left ventricular end-diastolic diameter (LVDd) in patients with T-wave alternans (TWA) was significantly larger than that
in patients without TWA (p , 0.05). No significant difference was observed in the percent fractional shortening (%FS) and QT dispersion
(QTd) between the two groups.
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were useful for risk stratification in the setting of DCM,
because of their low sensitivity for VT. This is consistent
with the results of the previous studies by Keeling et al. (9),
Turitto et al. (22) and Grimm et al. (6,7,23). The prognostic
value of the SAECG in DCM was reported to be inferior to
that in old myocardial infarction (21). However, studies that
have evaluated the prognostic value of the SAECG in
patients with DCM are not conclusive. Mancini et al. (24)
reported that an abnormal SAECG was a marker of past
and future arrhythmic events in patients with nonischemic
cardiomyopathy. The discrepancies between the study by
Mancini et al. and the present study may, in part, be due to
the differences in methods. Patients with a wide QRS
complex were excluded from analysis in the study by
Mancini et al. (24), whereas in this study patients with wide
QRS complex were included. Furthermore, it has been more
difficult to predict which patients might be at high risk for
arrhythmic sudden death.
T-wave alternans in patients with ischemic heart disease
and cardiomyopathies. In recent years, the presence of
subtle and visually inapparent beat-to-beat alternation in
the T-wave amplitude has been recognized as a harbinger of
life-threatening ventricular arrhythmias. Smith et al. first
reported a spectral method to measure microvolt-level
TWA and demonstrated a strong correlation between such
TWA and the extent of the decrease in the VF threshold
caused by hypothermia or coronary artery ligation in dogs
(12). In 1994, Rosenbaum et al. (14) documented a highly
significant relationship between microvolt-level TWA on
the electrocardiogram during atrial pacing measured with a
CH 2000 system and inducible sustained VT/VF as well as
arrhythmia-free survival in 83 patients with mainly coronary
artery disease. Murda’h et al. (25) reported that TWA was
correlated with the presence of clinical risk factors, such as
family history of sudden death, recurrent unexplained syn-
cope, nonsustained VT on Holter monitoring and a flat
blood pressure response on treadmill exercise (p , 0.005) in
patients with hypertrophic cardiomyopathy (HCM). They
also reported that TWA might be an important marker for
sustained VT/VF in patients with HCM, because five
patients with documented VT/VF were all TWA positive.
Momiyama et al. reported that TWA might be a useful
marker for ventricular arrhythmic risk in patients with
HCM (26). However, there were no reports in terms of the
significance of TWA in patients with DCM. Our present
study is the first to investigate the relationship between
TWA and risk stratification in patients with DCM by
controlled bicycle exercise testing using a CH 2000 system.
The results of our study demonstrated that there was no
significant difference in the NYHA class, %FS, SAECG or
QTd between patients with and those without TWA. The
percentage of patients with VT was significantly higher in
patients with TWA than those without TWA, and the
LVDd on M-mode and two-dimensional Doppler echocar-
diography was also significantly larger in patients with
TWA than those without TWA. Multivariate analysis
showed that VT was a major independent determinant of
TWA in patients with DCM. The results of this study
suggest that TWA may be helpful in identifying patients
with DCM who have VT. Hofmann et al. (3) reported that
left ventricular ejection fraction, cardiac index and ventric-
ular arrhythmias were independent predictors of cardiac
death in patients with DCM. Maria et al. (27) reported that
the severity of ventricular arrhythmias was a major indepen-
dent predictor of the prognosis in patients with DCM. In
patients with mild to moderate heart failure, VT frequency
recorded on Holter monitoring was independently associ-
ated with both total mortality and sudden death (14).
Therefore, TWA was useful for identifying the risk strati-
fication in the setting of DCM, because of its high sensi-
tivity for VT. The SAECG and QTd had a high specificity
for VT, but a low sensitivity for VT in patients with DCM.
The predictive value of TWA for VT was superior to that of
the SAECG and QTd.
Figure 3. No significant difference was observed in the signal-
averaged electrocardiogram (SAECG) between the two groups.
Ventricular tachycardia (VT) was documented in an extremely
high percentage of patients in the positive T-wave alternans
(TWA) group. Sustained VT was documented in two patients and
ventricular fibrillation in one. These three patients were TWA
positive.
Table 3. Univariate and Multivariate Analysis: Determinant
of TWA
Determinant
Factor
Univariate
Analysis,
p
Multivariate
Analysis*
OR p
NYHA 0.124 — —
LVDd 0.023 — —
%FS 0.085 — —
QTd 0.095 — —
SAECG 0.265 — —
VT ,0.001 4.00 0.003
*Logistic regression analysis using forward stepwise method. %FS 5 percent frac-
tional shortening; LVDd 5 left ventricular end-diastolic diameter; NYHA 5 New
York Heart Association class; OR 5 odds ratio; QTd 5 QT dispersion; SAECG 5
signal-averaged electrocardiogram; TWA 5 T-wave alternans; VT 5 ventricular
tachycardia.
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The mechanisms of TWA. In patients with coronary
artery disease, TWA has been reported to be closely related
to sustained VT/VF (14). In patients with DCM, TWA
was closely related with more than three consecutive beats of
premature ventricular contractions in the present study.
This difference could be due to patients with coronary artery
disease having a partial relatively damaged area of the
myocardium equivalent to obstructive coronary artery circu-
lation, whereas patients with DCM have a large diffuse area
of damaged myocardium. The mechanism of VT after
myocardial infarction is reentry through the infarct region
(28). On the other hand, the mechanisms and precise
electrophysiologic characteristics of VT in patients with
DCM are unclear; in addition, several factors may generate
ventricular arrhythmias in DCM. These include fibrosis
leading to uncoupling of cells, ventricular hypertrophy,
increase in cytosolic calcium, subendocardial ischemia, elec-
trolyte disturbances and others. Therefore, the cause of
sudden cardiac death in DCM may be multifactorial (29).
The proposed mechanisms for alternans-related arrhythmo-
genesis have been discussed previously. Two basic mecha-
nisms have been hypothesized. One mechanism is a popu-
lation mechanism, the other one is a cellular mechanism. It
is not known whether either one of these two mechanisms
actually pertains to alternans-related arrhythmogenesis in
man (13,30).
Study limitations. Several important factors must be con-
sidered in interpreting our results. Many of the patients with
DCM had atrial fibrillation or frequent ectopic beats, or
were pacemaker dependent. They must be excluded from
the study population because their electrocardiograms could
not be analyzed with the spectral method. In the present
study, 17% of patients with DCM were indeterminate for
TWA because of a high noise level with motion artifact or
a low heart rate level to detect TWA. We used %FS as a
cardiac function instead of left ventricular ejection fraction,
because left ventricular ejection fraction by left ventriculog-
raphy was performed outside the time frame of the study.
We did not elucidate the quantitative relationship between
TWA and inducible VT/VF in patients with DCM by
electrophysiologic test. Some patients with pseudopositive
TWA may have inducible VT/VF by electrophysiologic
test. T-wave alternans may be a useful noninvasive tool for
identifying high risk patients, but further studies are re-
quired to determine the test protocol and positivity criteria.
The present study did not include follow-up data, and
therefore, we must follow these patients in the long term.
Conclusions. Our results suggest that microvolt-level
TWA was closely related to ventricular tachycardia in
patients with DCM. T-wave alternans may be a useful
noninvasive tool for identifying high risk patients with
DCM who have VT. The independent determinant of
TWA in patients with DCM was VT.
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